About this item:

511 Views | 614 Downloads

Author Notes:

To whom correspondence should be addressed. E-mail: sk3295@columbia.edu

Financial Disclosures: None.

The authors report no conflicts of interest.

Subject:

Research Funding:

NINDS K08 NS083738, Louis V. Gerstner Jr. Scholarship, American Academy of Neurology Clinical Research Training Fellowship, Parkinson Disease Foundation, American Parkinson's Disease Association, Rare Disease Clinical Research Network (RDCRN) (RC1NS068897).

Keywords:

  • Hypertension
  • Hyperlipidemia
  • Vascular
  • Spinocerebellar ataxia
  • Neurodegeneration

Vascular Risk Factors and Clinical Progression in Spinocerebellar Ataxias

Show all authors Show less authors

Tools:

Journal Title:

Tremor and Other Hyperkinetic Movements

Volume:

Volume 5

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

Background: The contributions of vascular risk factors to spinocerebellar ataxia (SCA) are not known. Methods: We studied 319 participants with SCA 1, 2, 3, and 6 and repeatedly measured clinical severity using the Scale for Assessment and Rating of Ataxia (SARA) for 2 years. Vascular risk factors were summarized by CHA2DS2-VASc scores as the vascular risk factor index. We employed regression models to study the effects of vascular risk factors on ataxia onset and progression after adjusting for age, sex, and pathological CAG repeats. Our secondary analyses took hyperlipidemia into account. Results: Nearly 60% of SCA participants were at low vascular risks with CHA2DS2-VASc = 0, and 31% scored 2 or greater. Higher CHA2DS2-VASc scores were not associated with either earlier onset or faster progression of ataxia. These findings were not altered after accounting for hyperlipidemia. Discussion: Vascular risks are not common in SCAs and are not associated with earlier onset or faster ataxia progression.

Copyright information:

© 2015 Lo et al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote